Glabridin is a bioactive isoflavan predominantly produced in Glycyrrhiza species and is of significant pharmacological and industrial interest. However, its biosynthetic pathway remains incompletely resolved due to the involvement of multiple branching reactions and poorly characterized...
Pancreatic cancer is an aggressive cancer with a poor prognosis. Metabolic abnormalities are one of the hallmarks of pancreatic cancer, and pancreatic cancer cells can adapt to biosynthesis, energy intake and redox needs through metabolic reprogramming to tolerate nutrient deficiency and hypoxic ...